NEUROPACE INC (NPCE) Stock Analyst Ratings
USA - NASDAQ:NPCE - US6412881053 - Common Stock
9.94 USD
+0.08 (+0.81%)
10.13 USD
+0.19 (+1.91%)
ChartMill assigns a Buy % Consensus number of 84% to NPCE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.19. This target is 72.98% above the current price.
NPCE was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NPCE.
In the previous month the buy percentage consensus was at a similar level.
NPCE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-28 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-05 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-01-30 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-21 | UBS | Initiate | Buy |
| 2024-12-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-14 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-03-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-03-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-22 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-01-30 | Leerink Partners | Initiate | Outperform |
| 2023-12-27 | Lake Street | Reiterate | Buy -> Buy |
| 2023-12-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-24 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-05-05 | Morgan Stanley | Maintains | Underweight |
| 2023-03-03 | Morgan Stanley | Maintains | Underweight |
| 2023-02-22 | Lake Street | Initiate | Buy |
| 2023-01-06 | Morgan Stanley | Maintains | Underweight |
NEUROPACE INC / NPCE FAQ
Can you provide the average price target for NEUROPACE INC stock?
14 analysts have analysed NPCE and the average price target is 17.19 USD. This implies a price increase of 72.98% is expected in the next year compared to the current price of 9.94.
How do analysts rate NEUROPACE INC (NPCE)?
The consensus rating for NEUROPACE INC (NPCE) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NEUROPACE INC (NPCE)?
The number of analysts covering NEUROPACE INC (NPCE) is 14.